相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diastolic stiffness of the failing diabetic heart - Importance of fibrosis, advanced glycation end products, and myocyte resting tension
Loek van Heerebeek et al.
CIRCULATION (2008)
Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor γ in cardiac fibrosis
Evren Caglayan et al.
DIABETES (2008)
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease
Helene von Bibra et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus
Luuk J. Rijzewijk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects
Rutger W. van der Meer et al.
DIABETES (2007)
L-3-11C-lactate as a PET tracer of myocardial lactate metabolism:: A feasibility study
Pilar Herrero et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Metabolic imaging of myocardial triglyceride content:: Reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers
Rutger W. van der Meer et al.
RADIOLOGY (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis
Sonal Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Cardiac steatosis in diabetes mellitus -: A 1H-magnetic resonance spectroscopy study
Jonathan M. McGavock et al.
CIRCULATION (2007)
Diabetic cardiomyopathy revisited
Sihem Boudina et al.
CIRCULATION (2007)
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure
Helena Tuunanen et al.
CIRCULATION (2006)
Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus
P Herrero et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease -: A 16-week randomized, double-blind, placebo-controlled study
R Lautamäki et al.
DIABETES (2005)
Activation of PPARγ enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats
LS Golfman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Pioglitazone improves left ventricular diastolic function in patients with essential hypertension
T Horio et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Fatty acid metabolism is enhanced in type 2 diabetic hearts
AN Carley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Feasibility of tissue magnetic resonance imaging - A pilot study in comparison with tissue Doppler imaging and invasive measurement
BP Paelinck et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Determinants of subclinical diabetic heart disease
ZY Fang et al.
DIABETOLOGIA (2005)
Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: Effect of metformin administration
D Manzella et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus:: a systematic review
MG Wulffelé et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone
K Hällsten et al.
DIABETIC MEDICINE (2004)
Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus
M Diamant et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model
SK Kim et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2003)
Thiazolidinediones in type 2 diabetes mellitus - Current clinical evidence
M Diamant et al.
DRUGS (2003)
Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction
T Shiomi et al.
CIRCULATION (2002)
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes
MS Sutton et al.
DIABETES CARE (2002)
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance
P Iozzo et al.
DIABETES (2002)
Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction
SD Solomon et al.
CIRCULATION (2002)
Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat
T Tsuji et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
Myocardial fatty acid oxidation in patients with impaired glucose tolerance
J Knuuti et al.
DIABETOLOGIA (2001)
分享论文
